Q4410 Amchomatrixdl HCPCS Reimbursement

HCPCS Level II code Q4410 denotes Amchomatrixdl billed per square centimeter as an add-on product used in wound care and soft-tissue repair. It is reported in addition to a primary procedure when a clinician applies this biologic matrix to a wound bed. Nationally, add-on supply codes like Q4410 matter because they capture utilization and cost of adjunct biologic products that can materially affect episode-level spending and clinical decision-making in wound management.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how Q4410 is used across hospital outpatient departments, ambulatory surgical centers, and wound-care clinics, and summarizes common billing practices and coding contexts.

Readers will find benchmarks and guidance on typical service settings, billing considerations for reporting an add-on per-square-centimeter product, and clinical context about when a biologic matrix product is applied alongside a primary procedure. The report also identifies gaps where payer-specific coverage and coding guidance are not uniformly available and highlights how Q4410 interacts with procedure-level billing in wound care episodes.

Billing Code Overview

HCPCS Level II code Q4410 describes Amchomatrixdl, billed per square centimeter. This is an add-on, list separately in addition to primary procedure supply or graft product intended for use in wound care and soft tissue repair where a biologic matrix is applied to a wound bed.

Service type: Biologic graft / wound care product supplied per square centimeter
Typical site of service: Hospital outpatient departments, ambulatory surgical centers, wound care clinics, and other facilities where biologic matrix products are used as an adjunct to primary procedures

Clinical Context

A typical patient is an adult with a chronic, non-healing full-thickness skin wound such as a diabetic foot ulcer, venous leg ulcer, or traumatic wound that has failed standard wound care (debridement, offloading, infection control, and topical dressings). A wound care specialist or plastic surgeon evaluates the wound in an outpatient wound clinic or hospital outpatient department. After assessment and appropriate debridement and control of infection and comorbid factors, an acellular dermal matrix product is measured and applied to the wound bed as an adjunct to promote granulation and wound closure.

The clinical workflow includes wound assessment and documentation, wound bed preparation (sharp debridement and hemostasis), measurement of the wound surface area in square centimeters, selection and preparation of the Q4410 product (amchomatrixdl) sized to the defect, secure placement of the graft/matrix with sutures or dressings, and application of an appropriate dressing and offloading plan. Post-procedure wound care visits monitor graft integration, manage dressings, and determine need for additional grafting or definitive closure.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work or resources required are substantially greater than typically required for the procedure.

Taxonomy Code	Specialty	Notes
`207L00000X`	Plastic Surgery	Performs grafting and complex wound reconstruction and placement of dermal matrices.
`207P00000X`	Podiatry	Manages diabetic foot ulcers and performs application of graft materials to foot wounds.
`208600000X`	Wound Care Specialist	Clinicians focused on chronic wound management and application of advanced biologic products.
`207RH0000X`	Dermatology	Manages skin defects and may utilize dermal matrices for reconstructive purposes.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers are a common indication for advanced biologic matrices to promote healing.
`L97.411`	Non-pressure chronic ulcer of left heel and midfoot with necrosis of muscle	Chronic lower-extremity ulcers often require wound bed preparation and dermal matrices.
`L97.422`	Non-pressure chronic ulcer of right calf with necrosis of muscle	Indicates chronicity and tissue loss amenable to matrix application.
`I83.019`	Varicose veins of unspecified lower extremity with ulcer of unspecified site	Venous stasis ulcers may be treated with advanced wound products after venous management.
`S81.811A`	Open wound of right lower leg, initial encounter	Traumatic open wounds with tissue loss where dermal matrices may be used to assist closure.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11042`	Debridement, subcutaneous tissue, first 20 sq cm or less	Often performed immediately prior to placement of an acellular dermal matrix to prepare the wound bed.
`11043`	Debridement, muscle and/or fascia, first 20 sq cm or less	Used when deeper debridement is required before graft placement.
`15271`	Application of skin substitute graft to trunk, arms, legs; first 100 sq cm or less; first application	May be used when a coded skin substitute application is billed instead of or alongside product codes depending on payer rules.
`15275`	Application of skin substitute graft, initial placement, lower extremity; per 100 sq cm or less	Commonly used for lower extremity chronic wounds when billing graft application services.
`97605`	Negative pressure wound therapy (NPWT) initial application	May be applied after graft placement to stabilize the graft and promote incorporation.

OpenPayer

Summary & Overview

HCPCS Q4410: Amchomatrixdl per square centimeter